Journey Medical (NASDAQ:DERM) Downgraded by Wall Street Zen to Hold
Journey Medical (NASDAQ:DERM – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday. Several other analysts have also weighed in on DERM. Industrial Alliance Securities set a $10.50 target price on Journey Medical in a report on […]
Journey Medical (NASDAQ:DERM – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday. Several other analysts have also weighed in on DERM. Industrial Alliance Securities set a $10.50 target price on Journey Medical in a report on […]
